Potrero Hill Therapeutics

About The Fund

Potrero Hill Therapeutics is a venture capital firm that specializes in discovering and developing novel therapeutics. Their primary focus is on identifying strong pre-clinical therapeutic opportunities that have the potential to address significant markets. With a rigorous approach to due diligence, they prioritize projects that have druggable targets and a clear regulatory precedent, ensuring that these ventures have a feasible path towards development and approval. Founded in 2015 and headquartered in San Francisco, California, Potrero Hill Therapeutics was established by an experienced team of biopharmaceutical professionals who have a history of successful collaborations on early-stage drug discovery and development projects. They leverage their combined expertise to evaluate and invest in opportunities that demonstrate valid science. The firm's investment thesis revolves around guiding their portfolio companies through the critical stages of drug development, culminating in early clinical proof-of-concept. They seek to create strong intellectual property and achieve successful exits for their investments. Potrero Hill Therapeutics operates with a strong business model that emphasizes the efficient use of resources and capital. By engaging with their core leadership and dedicated drug development team, they maintain the agility required for swift decision-making and effective strategy implementation in the dynamic therapeutics sector. The firm plays an instrumental role in translating scientific discovery into clinically valuable assets.